About 通用幹細胞股份有限公司
通用幹細胞股份有限公司 is a company based in Taichung (Taiwan) founded in 2022. 通用幹細胞股份有限公司 offers products and services including Cell Culture Medium and Closed Cell Culture System.
- Headquarter Taichung, Taiwan
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Duogenic Stemcells Corporation
-
Annual Revenue
$12.05 M-11.82as on Dec 31, 2024
-
Net Profit
-$61.58 M-36.13as on Dec 31, 2024
-
EBITDA
-$53.73 M-41.86as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of 通用幹細胞股份有限公司
通用幹細胞股份有限公司 is a publicly listed company on the TPEX with ticker symbol 7607 in Taiwan, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of 通用幹細胞股份有限公司
通用幹細胞股份有限公司 offers a comprehensive portfolio of products and services, including Cell Culture Medium and Closed Cell Culture System.
Cell culture media are provided by DuoGenic StemCells for cultivating human cells in 2D and 3D environments, with these media being certified and suitable for research and clinical applications
A closed cell culture system is offered by DuoGenic StemCells using bags for cell growth, which is intended to lower production costs and support the expansion of cell therapy
Funding Insights of 通用幹細胞股份有限公司
Detailed funding history for 通用幹細胞股份有限公司
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by 通用幹細胞股份有限公司
Investment portfolio details for 通用幹細胞股份有限公司
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - 通用幹細胞股份有限公司
Detailed financials for 通用幹細胞股份有限公司
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
通用幹細胞股份有限公司 Comparisons
Peer comparison for 通用幹細胞股份有限公司
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of 通用幹細胞股份有限公司
Detailed competitors of 通用幹細胞股份有限公司
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on 通用幹細胞股份有限公司
Complete news archive for 通用幹細胞股份有限公司
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 通用幹細胞股份有限公司
通用幹細胞股份有限公司 was founded in 2022.
通用幹細胞股份有限公司 is headquartered in Taichung, Taiwan.
通用麵細胞股份有限公司 was founded in 2022 and is based in Taichung, Taiwan. Operations are managed from this location, with an online presence maintained through the domain dgsc.com.tw. The company functions as a limited liability entity, though specific sectors or services are not detailed in available records. Focus is placed on standard corporate activities in the Taiwanese market.
通用幹細胞股份有限公司 offers Cell Culture Medium and Closed Cell Culture System.
Yes, 通用幹細胞股份有限公司 is publicly traded on TPEX under the ticker symbol 7607.
The ticker symbol of 通用幹細胞股份有限公司 is 7607 on TPEX.